NYU and UCLA Awarded $2.4M from NIH to Further Study the Use of Non-Psychotropic Cannabinoids to…
NYU and UCLA Awarded $2.4M from NIH to Further Study the Use of Non Psychotropic Cannabinoids to Suppress Chronic Cancer Pain January 26, 2016 — NYU’s Bluestone Center for Clinical Research and UCLA Awarded $2.4M from NIH to Further Study